Business Wire

Q-State Publishes New Research on ASOs in Ultra-rare Neurodegenerative Disorder

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Q-State Biosciences (“Q-State”), a discovery technology and therapeutics company advancing programs for the treatment of serious nervous system disorders, today ...
Business Wire

Q-State Biosciences Announces Pre-Clinical Proof-of-Concept Data for Exon-Skipping ASO Therapeutic in Ultra-Rare Neurological Disorder

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Q-State Biosciences (“Q-State”), a discovery technology and therapeutics company advancing programs for the treatment of epilepsy, pain, and other disorders of the ...
BioWorld

TECPR2 deficiency causes autophagy dysfunction in hereditary sensory and autonomic neuropathy 9

The rare, deadly neurological disease called hereditary sensory and autonomic neuropathy 9 (HSAN9) is caused by mutations in the gene that encodes tectonin β-propeller repeat-containing protein 2 ...
Sun Sentinel

Family trying to raise $2.5M to save son battling incurable genetic disorder

Imagine a family in a race against the clock to save their son. For David and Stacey Ogman, of Boca Raton, this is their reality as their 4-year-old son, Jordan, is battling an untreatable and ...